ArticleOncotarget2017

A phase I clinical study of autologous dendritic cell therapy in patients with relapsed or refractory multiple myeloma.

Sung-Hoon Jung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.